Table of Contents Author Guidelines Submit a Manuscript
Dermatology Research and Practice
Volume 2014 (2014), Article ID 674709, 10 pages
http://dx.doi.org/10.1155/2014/674709
Review Article

Pathogenesis of Chronic Urticaria: An Overview

Skin Care Clinic, 108 Darya Ganj, New Delhi 110002, India

Received 14 April 2014; Accepted 15 June 2014; Published 10 July 2014

Academic Editor: Lajos Kemeny

Copyright © 2014 Sanjiv Jain. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. A. Sabroe and M. W. Greaves, “What is urticaria ? Anatomical, physiological, and histologic consideration and classification,” in Urticaria and Angioedema, A. P. Kaplan, Ed., pp. 1–14, Informo Health Care, New York, NY, USA, 2nd edition, 2009. View at Google Scholar
  2. J. Elias, E. Boss, and A. P. Kaplan, “Studies of the cellular infiltrate of chronic idiopathic urticaria: Prominence of T-lymphocytes, monocytes, and mast cells,” Journal of Allergy and Clinical Immunology, vol. 78, no. 5, pp. 914–918, 1986. View at Publisher · View at Google Scholar · View at Scopus
  3. Y. A. Mekori, R. C. Giorno, P. Anderson, and P. F. Kohler, “Lymphocyte subpopulations in the skin of patients with chronic urticaria,” Journal of Allergy and Clinical Immunology, vol. 72, no. 6, pp. 681–684, 1983. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Caproni, B. Giomi, W. Volpi et al., “Chronic idiopathic urticaria: infiltrating cells and related cytokines in autologous serum-induced wheals,” Clinical Immunology, vol. 114, no. 3, pp. 284–292, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. C. H. Smith, C. Kepley, L. B. Schwartz, and T. H. Lee, “Mast cell number and phenotype in chronic idiopathic urticaria,” Journal of Allergy and Clinical Immunology, vol. 96, no. 3, pp. 360–364, 1995. View at Publisher · View at Google Scholar · View at Scopus
  6. X. Valencia and P. E. Lipsky, “CD4+CD25+FoxP3+ regulatory T cells in autoimmune diseases,” Nature Clinical Practice Rheumatology, vol. 3, no. 11, pp. 619–626, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Leznoff, R. G. Josse, J. Denburg, and J. Dolovich, “Association of chronic urticaria and angioedema with thyroid autoimmunity,” Archives of Dermatology, vol. 119, no. 8, pp. 636–640, 1983. View at Publisher · View at Google Scholar · View at Scopus
  8. C. E. H. Grattan, T. B. Wallington, R. P. Warin, C. T. Kennedy, and J. W. Bradfield, “A serological mediator in chronic idiopathic urticaria—a clinical, immunological and histological evaluation,” British Journal of Dermatology, vol. 114, no. 5, pp. 583–590, 1986. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Hide, D. M. Francis, C. E. H. Grattan, J. Hakimi, J. P. Kochan, and M. W. Greaves, “Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria,” The New England Journal of Medicine, vol. 328, no. 22, pp. 1599–1604, 1993. View at Publisher · View at Google Scholar · View at Scopus
  10. C. E. H. Grattan, D. M. Francis, M. Hide, and M. W. Greaves, “Detection of circulating histamine releasing autoantibodies with functional properties of anti-IgE in chronic urticaria,” Clinical and Experimental Allergy, vol. 21, no. 6, pp. 695–704, 1991. View at Publisher · View at Google Scholar · View at Scopus
  11. B. F. O'Donnell, C. M. O'Neill, D. M. Francis et al., “Human leucocyte antigen class II associations in chronic idiopathic urticaria,” British Journal of Dermatology, vol. 140, no. 5, pp. 853–858, 1999. View at Publisher · View at Google Scholar · View at Scopus
  12. C. E. H. Grattan, D. M. Francis, N. G. P. Slater, R. J. Barlow, and M. W. Greaves, “Plasmapheresis for severe, unremitting, chronic urticaria,” The Lancet, vol. 339, no. 8801, pp. 1078–1080, 1992. View at Publisher · View at Google Scholar · View at Scopus
  13. B. F. O'Donnell, R. M. Barr, A. K. Black et al., “Intravenous immunoglobulin in autoimmune chronic urticaria,” British Journal of Dermatology, vol. 138, no. 1, pp. 101–106, 1998. View at Publisher · View at Google Scholar · View at Scopus
  14. U. Fagiolo, F. Kricek, C. Rufb, A. Peserico, A. Amadori, and M. Cancian, “Effects of complement inactivation and IgG depletion on skin reactivity to autologous serum in chronic idiopathic urticaria,” Journal of Allergy and Clinical Immunology, vol. 106, no. 3, pp. 567–572, 2000. View at Publisher · View at Google Scholar · View at Scopus
  15. E. Guttman-yassky, R. Bergman, C. Maor, M. Mamorsky, S. Pollack, and E. Shahar, “The autologous serum skin test in a cohort of chronic idiopathic urticaria patients compared to respiratory allergy patients and healthy controls,” Journal of the European Academy of Dermatology and Venereology, vol. 21, no. 1, pp. 35–39, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. N. R. Rose and C. Bona, “Defining criteria for autoimmune diseases (Witebsky's postulates revisited),” Immunology Today, vol. 14, no. 9, pp. 426–430, 1993. View at Publisher · View at Google Scholar · View at Scopus
  17. M. P. Horn, J. M. Pachlopnik, M. Vogel et al., “Conditional autoimmunity mediated by human natural anti-FcεRIα autoantibodies?” FASEB Journal, vol. 15, no. 12, pp. 2268–2274, 2001. View at Publisher · View at Google Scholar · View at Scopus
  18. E. Novembre, A. Cianferoni, F. Mori et al., “Urticaria and urticaria related skin condition/disease in children,” European Annals of Allergy and Clinical Immunology, vol. 39, no. 8, pp. 253–258, 2007. View at Google Scholar · View at Scopus
  19. E. Fiebiger, F. Hammerschmid, G. Stingl, and D. Maurer, “Anti-FcεRIα autoantibodies in autoimmune-mediated disorders: identification of a structure-function relationship,” Journal of Clinical Investigation, vol. 101, no. 1, pp. 243–251, 1998. View at Publisher · View at Google Scholar · View at Scopus
  20. Y. Kikuchi and A. P. Kaplan, “A role for C5a in augmenting IgG-dependent histamine release from basophils in chronic urticaria,” Journal of Allergy and Clinical Immunology, vol. 109, no. 1, pp. 114–118, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. W. Zhao and L. B. Schwartz, “Mast cells and basophils,” in Urticaria and Angioedema, M. W. Greaves and A. P. Kaplan, Eds., pp. 19–50, Marcel Dekker, New York, NY, USA, 2004. View at Google Scholar
  22. C. E. H. Grattan, “Autoimmune urticaria,” Immunology and Allergy Clinics of North America, vol. 24, no. 2, pp. 163–181, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. A. P. Kaplan and M. Greaves, “Pathogenesis of chronic urticaria,” Clinical and Experimental Allergy, vol. 39, no. 6, pp. 777–787, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. A. L. Schocket, “Chronic urticaria: pathophysiology and etiology, or the what and why,” Allergy and Asthma Proceedings, vol. 27, no. 2, pp. 90–95, 2006. View at Google Scholar · View at Scopus
  25. C. E. H. Grattan, G. Dawn, S. Gibbs, and D. M. Francis, “Blood basophil numbers in chronic ordinary urticaria and healthy controls: diurnal variation, influence of loratadine and prednisolone and relationship to disease activity,” Clinical & Experimental Allergy, vol. 33, no. 3, pp. 337–341, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. R. A. Sabroe, D. M. Francis, R. M. Barr, A. K. Black, and M. W. Greaves, “Anti-FcεRI autoantibodies and basophil histamine releasability in chronic idiopathic urticaria,” Journal of Allergy and Clinical Immunology, vol. 102, no. 4 I, pp. 651–658, 1998. View at Publisher · View at Google Scholar · View at Scopus
  27. E. Luquin, A. P. Kaplan, and M. Ferrer, “Increased responsiveness of basophils of patients with chronic urticaria to sera but hypo-responsiveness to other stimuli,” Clinical and Experimental Allergy, vol. 35, no. 4, pp. 456–460, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. B. M. Vonakis and S. S. Saini, “New concepts in chronic urticaria,” Current Opinion in Immunology, vol. 20, no. 6, pp. 709–716, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. D. W. MacGlashan Jr., “Relationship between spleen tyrosine kinase and phosphatidylinositol 5′ phosphatase expression and secretion from human basophils in the general population,” Journal of Allergy and Clinical Immunology, vol. 119, no. 3, pp. 626–633, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. W. Leung and S. Bolland, “The inositol 5′-phosphatase SHIP-2 negatively regulates IgE-induced mast cell degranulation and cytokine production,” Journal of Immunology, vol. 179, no. 1, pp. 95–102, 2007. View at Google Scholar · View at Scopus
  31. B. M. Vonakis and S. S. Saini, “Syk-deficient basophils from donors with chronic idiopathic urticaria exhibit a spectrum of releasability,” Journal of Allergy and Clinical Immunology, vol. 121, no. 1, pp. 262–264, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. B. M. Vonakis, K. Vasagar, S. P. Gibbons Jr. et al., “Basophil FcεRI histamine release parallels expression of Src-homology 2-containing inositol phosphatases in chronic idiopathic urticaria,” Journal of Allergy and Clinical Immunology, vol. 119, no. 2, pp. 441–448, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. J. A. Eckman, R. G. Hamilton, L. M. Gober, P. M. Sterba, and S. S. Saini, “Basophil phenotypes in chronic idiopathic urticaria in relation to disease activity and autoantibodies,” Journal of Investigative Dermatology, vol. 128, no. 8, pp. 1956–1963, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Tedeschi, R. Asero, A. V. Marzano et al., “Plasma levels and skin-eosinophil-expression of vascular endothelial growth factor in patients with chronic urticaria,” Allergy, vol. 64, no. 11, pp. 1616–1622, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. H. L. Kwang, Y. K. Ji, D. Kang, J. C. Yoo, W. Lee, and Y. R. Jai, “Increased expression of endothelial cell adhesion molecules due to mediator release from human foreskin mast cells stimulated by autoantibodies in chronic urticaria sera,” Journal of Investigative Dermatology, vol. 118, no. 4, pp. 658–663, 2002. View at Publisher · View at Google Scholar · View at Scopus
  36. A. S. Kirshenbaum, C. Akin, Y. Wu et al., “Characterization of novel stem cell factor responsive human mast cell lines LAD 1 and 2 established from a patient with mast cell sarcoma/leukemia; Activation following aggregation of FcεRI or FcγRI,” Leukemia Research, vol. 27, no. 8, pp. 677–682, 2003. View at Publisher · View at Google Scholar · View at Scopus
  37. G. Nilsson, T. Blom, M. Kusche-Gullberg et al., “Phenotypic characterization of the human mast-cell line HMC-1,” Scandinavian Journal of Immunology, vol. 39, no. 5, pp. 489–498, 1994. View at Publisher · View at Google Scholar · View at Scopus
  38. F. Bossi, B. Frossi, O. Radillo et al., “Mast cells are critically involved in serum-mediated vascular leakage in chronic urticaria beyond high-affinity IgE receptor stimulation,” Allergy, vol. 66, no. 12, pp. 1538–1545, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. B. Frossi, G. Gri, C. Tripodo, and C. Pucillo, “Exploring a regulatory role for mast cells: MCregs?” Trends in Immunology, vol. 31, no. 3, pp. 97–102, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. F. Levi-Schaffer and J. Pe'Er, “Mast cells and angiogenesis,” Clinical and Experimental Allergy, vol. 31, no. 4, pp. 521–524, 2001. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Hennino, F. Bérard, I. Guillot, N. Saad, A. Rozières, and J. Nicolas, “Pathophysiology of urticaria,” Clinical Reviews in Allergy and Immunology, vol. 30, no. 1, pp. 3–11, 2006. View at Publisher · View at Google Scholar · View at Scopus
  42. J. A. Eckman, R. G. Hamilton, and S. S. Saini, “Independent evaluation of a commercial test for autoimmune urticaria in normal and chronic urticaria subjects,” Journal of Investigative Dermatology, vol. 129, no. 6, pp. 1584–1586, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. F. Habal and V. Huang, “Angioedema associated with Crohn's disease: response to biologics,” World Journal of Gastroenterology, vol. 18, no. 34, pp. 4787–4790, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. E. Futata, M. Azor, J. Dos Santos et al., “Impaired IFN-α secretion by plasmacytoid dendritic cells induced by TLR9 activation in chronic idiopathic urticaria,” British Journal of Dermatology, vol. 164, no. 6, pp. 1271–1279, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. G. Hartmann, J. Battiany, H. Poeck et al., “Rational design of new CpG oligonucleotides that combine B cell activation with high IFN-α induction in plasmacytoid dendritic cells,” European Journal of Immunology, vol. 33, no. 6, pp. 1633–1641, 2003. View at Publisher · View at Google Scholar · View at Scopus
  46. J. R. Tversky, T. V. Le, A. P. Bieneman, K. L. Chichester, R. G. Hamilton, and J. T. Schroeder, “Human blood dendritic cells from allergic subjects have impaired capacity to produce interferon-α via toll-like receptor 9,” Clinical and Experimental Allergy, vol. 38, no. 5, pp. 781–788, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. A. Dzionek, Y. Sohma, J. Nagafune et al., “BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon α/β induction,” Journal of Experimental Medicine, vol. 194, no. 12, pp. 1823–1834, 2001. View at Publisher · View at Google Scholar · View at Scopus
  48. A. Fuchs, M. Cella, T. Kondo, and M. Colonna, “Paradoxic inhibition of human natural interferon-producing cells by the activating receptor NKp44,” Blood, vol. 106, no. 6, pp. 2076–2082, 2005. View at Publisher · View at Google Scholar · View at Scopus
  49. W. Cao, D. B. Rosen, T. Ito et al., “Plasmacytoid dendritic cell-specific receptor ILT7-FcεRIγ inhibits Toll-like receptor-induced interferon production,” Journal of Experimental Medicine, vol. 203, no. 6, pp. 1399–1405, 2006. View at Publisher · View at Google Scholar · View at Scopus
  50. A. Mazzoni, C. A. Leifer, G. E. Mullen, M. N. Kennedy, D. M. Klinman, and D. M. Segal, “Cutting edge: histamine inhibits IFN-α release from plasmacytoid dendritic cells,” The Journal of Immunology, vol. 170, no. 5, pp. 2269–2273, 2003. View at Publisher · View at Google Scholar · View at Scopus
  51. J. C. dos Santos, M. H. Azor, V. Y. Nojima et al., “Increased circulating pro-inflammatory cytokines and imbalanced regulatory T-cell cytokines production in chronic idiopathic urticaria,” International Immunopharmacology, vol. 8, no. 10, pp. 1433–1440, 2008. View at Publisher · View at Google Scholar · View at Scopus
  52. M. Caproni, C. Cardinali, B. Giomi et al., “Serological detection of eotaxin, IL-4, IL-13, IFN-γ, MIP-1α, TARC and IP-10 in chronic autoimmune urticaria and chronic idiopathic urticaria,” Journal of Dermatological Science, vol. 36, no. 1, pp. 57–59, 2004. View at Publisher · View at Google Scholar · View at Scopus
  53. A. Tedeschi, M. Lorini, C. Suli, and R. Asero, “Serum interleukin-18 in patients with chronic ordinary urticaria: association with disease activity,” Clinical and Experimental Dermatology, vol. 32, no. 5, pp. 568–570, 2007. View at Publisher · View at Google Scholar · View at Scopus
  54. F. Melchers, “Actions of BAFF in B-cell maturation and its effects on the development of autoimmune disease,” Annals of the Rheumatic Diseases, vol. 62, supplement 2, pp. 1125–1127, 2013. View at Google Scholar
  55. G. Ciprandi, M. de Amici, L. Berardi et al., “Serum neopterin levels in spontaneous urticaria and atopic dermatitis,” Clinical and Experimental Dermatology, vol. 36, no. 1, pp. 85–87, 2011. View at Publisher · View at Google Scholar · View at Scopus
  56. J. C. Santos, C. A. de Brito, E. A. Futata et al., “Up-regulation of chemokine C-C ligand 2 (CCL2) and C-X-C chemokine 8 (CXCL8) expression by monocytes in chronic idiopathic urticaria,” Clinical and Experimental Immunology, vol. 167, no. 1, pp. 129–136, 2012. View at Publisher · View at Google Scholar · View at Scopus
  57. R. Bonecchi, G. Bianchi, P. P. Bordignon et al., “Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s,” Journal of Experimental Medicine, vol. 187, no. 1, pp. 129–134, 1998. View at Publisher · View at Google Scholar · View at Scopus
  58. M. Rotondi, A. Rosati, A. Buonamano et al., “High pretransplant serum levels of CXCL10/IP-10 are related to increased risk of renal allograft failure,” American Journal of Transplantation, vol. 4, no. 9, pp. 1466–1474, 2004. View at Publisher · View at Google Scholar · View at Scopus
  59. W. J. Karpus, N. W. Lukacs, K. J. Kennedy et al., “Differential CC chemokine-induced enhancement of T helper cell cytokine production,” The Journal of Immunology, vol. 158, no. 9, pp. 4129–4136, 1997. View at Google Scholar · View at Scopus
  60. F. D. Lourenço, M. H. Azor, J. C. Santos et al., “Activated status of basophils in chronic urticaria leads to interleukin-3 hyper-responsiveness and enhancement of histamine release induced by anti-IgE stimulus,” British Journal of Dermatology, vol. 158, no. 5, pp. 979–986, 2008. View at Publisher · View at Google Scholar · View at Scopus
  61. M. L. Castellani, M. A. De Lutiis, E. Toniato et al., “Impact of RANTES, MCP-1 and IL-8 in mast cells,” Journal of Biological Regulators & Homeostatic Agents, vol. 24, no. 1, pp. 1–6, 2010. View at Google Scholar · View at Scopus
  62. R. Asero, A. Tedeschi, P. Riboldi, and M. Cugno, “Plasma of patients with chronic urticaria shows signs of thrombin generation, and its intradermal injection causes wheal-and-flare reactions much more frequently than autologous serum,” Journal of Allergy and Clinical Immunology, vol. 117, no. 5, pp. 1113–1117, 2006. View at Publisher · View at Google Scholar · View at Scopus
  63. V . Safedi, M. Morahedi, A. Aghamohammed et al., “Comparison between sensitivity of autologous skin serum test and autologous plasma skin test in patients with Chronic Idiopathic Urticaria for detection of antibody against IgE or IgE receptor (FcεRIα),” Iranian Journal of Allergy, Asthma, and Immunology, vol. 10, no. 2, pp. 111–117, 2011. View at Google Scholar
  64. R. Asero, A. Tedeschi, R. Coppola et al., “Activation of the tissue factor pathway of blood coagulation in patients with chronic urticaria,” Journal of Allergy and Clinical Immunology, vol. 119, no. 3, pp. 705–710, 2007. View at Publisher · View at Google Scholar · View at Scopus
  65. R. Parslew, D. Pryce, J. Ashworth, and P. S. Friedmann, “Warfarin treatment of chronic idiopathic urticaria and angio-oedema,” Clinical & Experimental Allergy, vol. 30, no. 8, pp. 1161–1165, 2000. View at Publisher · View at Google Scholar · View at Scopus
  66. R. J. Barlow and M. W. Greaves, “Warfarin in the treatment of chronic urticaria/angio-oedema,” British Journal of Dermatology, vol. 126, no. 4, pp. 415–416, 1992. View at Google Scholar · View at Scopus
  67. M. Metz, A. Giménez-Arnau, E. Borzova, C. E. Grattan, M. Magerl, and M. Maurer, “Frequency and clinical implications of skin autoreactivity to serum versus plasma in patients with chronic urticaria,” Journal of Allergy and Clinical Immunology, vol. 123, no. 3, pp. 705–706, 2009. View at Publisher · View at Google Scholar · View at Scopus
  68. S. S. Saini, “Chronic spontaneous urticaria: etiology and pathogenesis,” Immunology and Allergy Clinics of North America, vol. 34, pp. 33–52, 2014. View at Google Scholar
  69. U. Amara, M. A. Flierl, D. Rittirsch et al., “Molecular intercommunication between the complement and coagulation systems,” The Journal of Immunology, vol. 185, no. 9, pp. 5628–5636, 2010. View at Publisher · View at Google Scholar · View at Scopus
  70. M. Kaliner, J. H. Shelhamer, and E. A. Ottesen, “Effects of infused histamine: correlation of plasma histamine levels and symptoms,” Journal of Allergy and Clinical Immunology, vol. 69, no. 3, pp. 283–289, 1982. View at Publisher · View at Google Scholar · View at Scopus
  71. W. Lorenz and A. Doenicke, “Histamine release in clinical conditions,” Mount Sinai Journal of Medicine, vol. 45, no. 3, pp. 357–386, 1978. View at Google Scholar · View at Scopus
  72. R. J. Flower, E. A. Harvey, and W. P. Kingston, “Inflammatory effects of prostaglandin D2 in rat and human skin,” British Journal of Pharmacology, vol. 56, no. 2, pp. 229–233, 1976. View at Publisher · View at Google Scholar · View at Scopus
  73. C. Grunfeld and M. A. Palladino Jr., “Tumor necrosis factor: immunologic, antitumor, metabolic, and cardiovascular activities,” Advances in Internal Medicine, vol. 35, pp. 45–71, 1990. View at Google Scholar · View at Scopus
  74. L. Borish, “Cytokines in allergic inflammation,” in Allergy : Principles and Practice, E. Middleton Jr., C. E. Reed, E. F. Ellis, N. F. Adkinson, J. W. Yunginger, and W. W. Busse, Eds., vol. 1, pp. 108–119, Mosby, St. Louis, Mo, USA, 5th edition, 1998. View at Google Scholar
  75. N. Subramanian and M. A. Bray, “Interleukin 1 releases histamine from human basophils and mast cells in vitro,” The Journal of Immunology, vol. 138, no. 1, pp. 271–275, 1987. View at Google Scholar · View at Scopus
  76. H. Boey, R. Rosenbaum, J. Castracane, and L. Borish, “Interleukin-4 is a neutrophil activator,” Journal of Allergy and Clinical Immunology, vol. 83, no. 5, pp. 978–984, 1989. View at Publisher · View at Google Scholar · View at Scopus
  77. J. M. Wang, A. Rambaldi, A. Biondi, Z. G. Chen, C. J. Sanderson, and A. Mantovani, “Recombinant human interleukin 5 is a selective eosinophil chemoattractant,” European Journal of Immunology, vol. 19, no. 4, pp. 701–705, 1989. View at Publisher · View at Google Scholar · View at Scopus
  78. J. Willems, M. Joniau, S. Cinque, and J. van Damme, “Human granulocyte chemotactic peptide (IL-8) as a specific neutrophil degranulator: comparison with other monokines,” Immunology, vol. 67, no. 4, pp. 540–542, 1989. View at Google Scholar · View at Scopus
  79. A. D. Luster, “Mechanisms of disease: chemokines chemotactic cytokines that mediate inflammation,” The New England Journal of Medicine, vol. 338, no. 7, pp. 436–445, 1998. View at Publisher · View at Google Scholar · View at Scopus